medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2017, Number 1

Next >>

Rev Mex Urol 2017; 77 (1)

Alphablockers in patients with benign prostatic hyperplasia complicated by overactive bladder: Are they all equally effective? SNIPER study

Alcántara MA

Language: Spanish
References: 8
Page: 1-3
PDF size: 142.45 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, et al. Clinical guidelines for overactive bladder. Int J Urol. 2009;16:126-42.

  2. Alcántara Montero A. Papel de los alfabloqueantes en el tratamiento de los síntomas del tracto urinario inferior/ hiperplasia benigna de próstata: ¿son todos iguales? Silodosina en la “vida real”. Semergen. 2016;42(Supl 2):1-9

  3. Shirakawa T, Haraguchi T, Shigemura K, Morishita S, Minayoshi K, Miyazaki J, et al. Silodosin versus naftopidil in Japanese patients with lower urinary tract symptoms associated with benignprostatic hyperplasia: a randomized multicenter study. Int J Urol. 2013;20:903-10.

  4. Yamaguchi K, Aoki Y, Yoshikawa T, Hachiya T, Saito T, Takahashi S. Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: a multicenter randomized trial. Int J Urol. 2013;20:1234-8.

  5. Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T. Comparison of two alpha1- adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatmentof lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int. 2006 ;97:747-51.

  6. Ukimura O, Kanazawa M, Fujihara A, Kamoi K, Okihara K, Miki T, et al. Naftopidil versus tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatichyperplasia with specialreference to the storage symptom: a prospective randomized controlled study. Int J Urol. 2008;15:1049-54.

  7. Perumal C, Chowdhury PS, Ananthakrishnan N, Nayak P, Gurumurthy S. A comparison of the efficacy of naftopidil and tamsulosin hydrochloride inmedicaltreatment of benignprostatic enlargement. Urol Ann. 2015;7:74-8.

  8. Matsukawa Y, Funahashi Y, Takai S, Majima T,Ogawa T, Narita H, et al. Comparison of silodosin and naftopidil for efficacy in the treatment of benign prostatic enlargement complicated by overactive bladder: A randomized, prospective study (SNIPER study). J Urol. 2016. doi: 10.1016/j.juro.2016.08.111.




2020     |     www.medigraphic.com